Cargando…
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
PURPOSE: In patients with primary hyperparathyroidism (PHPT) and severe hypercalcemia, parathyroidectomy remains the only curative therapy. During the coronavirus disease 2019 (COVID-19) pandemic, when many hospital visits are suspended and surgeries cannot be performed, the management of these pati...
Autor principal: | Alfadhli, Eman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976275/ https://www.ncbi.nlm.nih.gov/pubmed/33752899 http://dx.doi.org/10.1016/j.clinthera.2021.02.003 |
Ejemplares similares
-
Denosumab for management of severe hypercalcemia in primary hyperparathyroidism
por: Eremkina, Anna, et al.
Publicado: (2020) -
Concurrent Primary Hyperparathyroidism and Sarcoidosis in a Patient With Severe Hypercalcemia
por: Ayyad, Mohammed, et al.
Publicado: (2023) -
MON-LB64 Primary Hyperparathyroidism With Severe Hypercalcemia During Pregnancy: A Challenging Diagnosis and Management
por: George, Gemy M, et al.
Publicado: (2020) -
PSAT214 Management of Hyperparathyroidism Associated with Severe Hypercalcemia Presenting During Labour
por: Mendez, Juan Vasquez, et al.
Publicado: (2022) -
ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
por: Mangaraj, Swayamsidha, et al.
Publicado: (2022)